Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannaRoyalty Corp C.CRZ

Origin House is a growing cannabis product and brands company operating across key markets in the U.S. and Canada. The company delivers over 130 branded cannabis products to the licensed dispensaries. It provides distribution, manufacturing, cultivation and marketing services for its brand partners. The company operates through two operating segments, The Corporate segment derives income from non-operating investment and The California Operations segment engaged in cultivation, manufacturing, an


CSE:CRZ - Post by User

Post by Oldweedon Apr 26, 2019 7:21pm
176 Views
Post# 29677569

Interesting Comment!!

Interesting Comment!!Take a close look at the last two paragraph!! Your not gonna get a better hint than that!!

Chicago-based Cresco Labs Inc., which recently acquired Canada’s Origin House for $1.1 billion, reported fourth-quarter results on Wednesday with US$17 million revenue and an adjusted EBITDA (earnings before interest, tax, depreciation and amortization) of US$13.7 million, compared to US$3.3 million in revenue and an adjusted EBITDA loss of US$3.1 million a year earlier. While those figures still pale in comparison to some Canadian players, Cresco’s CEO Charles Bachtell said he would welcome any competition from Canada’s pot giants.

“The way I look at that is, the second that they're actually able to execute and come into the U.S. will be the same second that I'm able to access the U.S. capital markets. So, I'll take that trade,” Bachtell said.

White noted that the Canadian cannabis companies were likely to be working out ways to enter the U.S., given the relative valuations between U.S. and Canadian pot firms mean potential all-stock deals make sense.

“I realize there are lots of impediments to that, namely it's federally illegal in the U.S.,” White said. “And if you're listed on a major exchange, you've got to get really smart about how you structure that that opportunity. But the really smart guys are going to figure it out.”

However, one chief executive of a U.S. cannabis operator who declined to be named made an interesting observation following the Canopy-Acreage announcement. The CEO, who declined to speak on the record as he doesn’t want to risk future M&A opportunities, said the structure introduced by Canopy to enter the U.S. signalled to the market that any company can now target deals with U.S. pot companies, not just Canadian firms.

“There’s nothing here to say that any other company can’t get into this space,” the CEO said. “Why would you take [stock] from a company like Aurora Cannabis or Cronos Group? Or you could wait and do a deal with Coca-Cola or Diageo.”

Full Article: https://www.bnnbloomberg.ca/could-canopy-s-us-3-4b-deal-for-acreage-shake-up-u-s-pot-firms-playbooks-1.1249937

<< Previous
Bullboard Posts
Next >>